Secukinumab in ankylosing spondylitis or psoriatic arthritis: Added benefit not proven

(Institute for Quality and Efficiency in Health Care) Drug manufacturer presented no relevant data and claimed no added benefit. Notable was the non-publication of literature searches and analyses.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news